| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Novavax Inc (NVAX) has 8 insiders with recent SEC Form 4 filings, including 0 buys and 95 sells. NVAX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 264.1K | $2.38M | - | |
| CFO | 145.1K | $1.31M | - | |
| VP | 112.7K | $1.01M | - | |
| VP | 34.9K | $313.9K | - | |
| Dir | 28.5K | $256.4K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 7, 2021 | Trizzino John86 | EVP, CMO And Cbo | Sale+OE | 17,913 | $112.34 | $2,012,352.59 | -35.3% | |
| Dec 31, 2020 | Young James F82 | Director | Sale+OE | 11,000 | $113.09 | $1,244,014.50 | -84.6% | |
| Nov 16, 2020 | Erck Stanley C86 | President And CEO | Sale+OE | 52,316 | $90.65 | $4,742,666.96 | -16.6% | |
| Oct 1, 2020 | Erck Stanley C86 | President And CEO | Sell | 12,233 | $110.23 | $1,348,417.52 | -4.5% | |
| Sep 30, 2020 | Trizzino John86 | EVP, Cbo And CFO | Sell | 2,250 | $110.22 | $248,001.77 | -4.6% | |
| Sep 29, 2020 | Herrmann John A III91 | EVP, Chief Legal Officer | Sale+OE | 42,779 | $109.04 | $4,664,546.09 | -12.8% | |
| Sep 29, 2020 | Glenn Gregory M88 | President, R&D | Sale+OE | 44,949 | $108.84 | $4,892,299.82 | -11.7% | |
| Sep 29, 2020 | Trizzino John86 | EVP, Cbo And CFO | Sale+OE | 43,321 | $109.03 | $4,723,085.66 | -9.4% | |
| Sep 29, 2020 | Erck Stanley C86 | President And CEO | Sale+OE | 29,112 | $109.95 | $3,200,722.15 | -4.5% | |
| Aug 18, 2020 | McManus Michael A Jr81 | Director | Sale+OE | 8,000 | $146.00 | $1,168,000.00 | -44.6% |